Dr. Ferrari, one of the trailblazers of nanotechnology, the current President Designate of the European Research Council of the E.U., and the recently retired President and CEO of Houston Methodist Research Institute begins by explaining how he views math as a creative art. He maps theorem and proof onto the creative endeavor and posits that in the same way that the artist envisions the work, a mathematician envisions or intuits the theorem and then has to discover how to get there. He argues that this process of intuition provides the map, and the proof is the, potentially, frustrating process of bringing the inner world into the outer world. Dr. Ferrari, a medical doctor and engineer speaks of concepts such as awe, infinity, creativity, intuition, and dreams. This conversation explores what Dr. Ferrari identifies as the three phases of his life – his training and early history, the many academic languages that he speaks, the descent into personal chaos, and how dark moments such as these paved the way for him to seek to join in the fight for humanity as we seek to end the power that cancer has had over our lives.

Bio:

Mauro Ferrari, Ph.D. – Biosketch (Updated June 2, 2019)

Current Positions (Selected): President Designate, European Research Council of the European Union (primary funding agency for research in the 28 member Countries of EU); Director, Arrowhead Pharmaceuticals (NASDAQ:ARWR); Executive Vice President for Strategic Initiatives and Community Partnerships, and Professor, University of St. Thomas; Advisor, Houston Methodist Hospital and Research Institute.

Education: Mathematics (Padova, Italy, 1985, Dottore); Mechanical Engineering (University of California Berkeley, 1987, MS and 1989, PhD); Medicine (Ohio State University, 2002-2003, no degree); Business Administration (Wharton, 2016, Harvard Business School, 2017, no degree).

Professional History (Selected): 1988-1990 Universita’ di Udine, Italy (Ricercatore, Assistant Professor Civil Engineering); 1991-1998 University of California Berkeley (Assistant and Associate Professor with tenure, Civil and Environmental Engineering, Materials Science and Engineering, Bioengineering); 1998-2006 The Ohio State University (Full Professor with tenure and endowed chair, Biomedical Engineering, Mechanical Engineering, Internal Medicine, Director of Biomedical Engineering, Associate Director Davis Heart and Lung Research Institute, Associate Vice President Health Science Technology Commercialization); 2003-2005 National Cancer Institute (Special Expert on Nanomedicine and Advisor to Director, concurrent with OSU); 2006-2010 University of Texas Medical School Houston, and MD Anderson Cancer Center (Full Professor with tenure and endowed chair, Internal Medicine, Experimental Therapeutics, Biomedical Engineering and Nanomedicine); 2010-2019 Houston Methodist Hospital (HMH) and Research Institute (HMRI) (Full professor with presidential endowed chair, President and CEO of HMRI, Executive Vice President of HMH, Chief Commercialization Officer).

Publications: About 500 publications in leading archival journals, including 27 primary papers, reviews, and features in Nature journals (4 covers). Bibliometrics as of February 6, 2019: 57471 citations, h-index = 107, i10-index = 836 (Google Scholar); 21699 citations, h-index = 69 (SCOPUS); 22546 citations, h-index = 72 (ISI Web of Science).

Theme music provided by:

http://www.modernnationsmusic.com

Band of the week: Alan

Album: Alan, the Universal answer is both

https://music.apple.com/us/album/alan-the-universal-answer-is-both/425467149

Learn more about this project at:

http://www.thesacredspeaks.com

Instagram:

https://www.instagram.com/thesacredspeaks/

Twitter:

https://twitter.com/thesacredspeaks

Facebook:

https://www.facebook.com/thesacredspeaks/